|
|
Previous Article | Table of Contents | Next Article 
Hematopoietic progenitor cells from patients with adult T-cell leukemia-
lymphoma are not infected with human T-cell leukemia virus type 1
K Nagafuji, M Harada, T Teshima, T Eto, Y Takamatsu, T Okamura, M Murakawa, K Akashi and Y Niho
First Department of Internal Medicine, Faculty of Medicine, Kyushu
University, Fukuoka, Japan.
The in vivo host range of human T-cell leukemia virus type 1 (HTLV-1) has
not been definitively established. To determine if hematopoietic stem cells
from patients with adult T-cell leukemia-lymphoma (ATL) are infected with
HTLV-1, we used a clonogenic progenitor assay followed by the polymerase
chain reaction for the detection of HTLV-1 DNA. In vitro growth
characteristics of myeloid (CFU-GM) and erythroid (BFU-E) progenitor cells
among nonadherent T-cell-depleted bone marrow (BM) mononuclear cells
(NA-T-MNCs) from 10 patients with ATL was not significantly different from
those of HTLV-1-seronegative controls (P = .20); numbers of colonies per 1
x 10(5) NA-T-MNCs were 34.9 +/- 7.6 for CFU-GM and 39.0 +/- 12.5 for BFU-E
in patients with ATL, whereas those were 32.1 +/- 9.5 for CFU-GM and 41.4
+/- 12.7 for BFU-E in normal controls. HTLV-1 DNA was not detected in
individual colonies formed by CD34+ cells from any of the patients.
Similarly HTLV-1 DNA was not detected in 1 x 10(3) CD34+ cells sorted on a
fluorescence-activated cell sorter (FACS) from six patients with ATL
studied. In contrast, HTLV-1 DNA was detected in BM mononuclear cells from
all patients. These observations clearly indicate that hematopoietic
progenitor cells from patients with ATL are normal in their colony-forming
capacity and that CD34+ cells from patients with ATL are not infected with
HTLV-1 in vivo.
Volume 82,
Issue 9,
pp. 2823-2828,
11/01/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Tripp, P. Banerjee, M. Sieburg, V. Planelles, F. Li, and G. Feuer
Induction of Cell Cycle Arrest by Human T-Cell Lymphotropic Virus Type 1 Tax in Hematopoietic Progenitor (CD34+) Cells: Modulation of p21cip1/waf1 and p27kip1 Expression
J. Virol.,
November 15, 2005;
79(22):
14069 - 14078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ishida, S. Iida, Y. Akatsuka, T. Ishii, M. Miyazaki, H. Komatsu, H. Inagaki, N. Okada, T. Fujita, K. Shitara, et al.
The CC Chemokine Receptor 4 as a Novel Specific Molecular Target for Immunotherapy in Adult T-Cell Leukemia/Lymphoma
Clin. Cancer Res.,
November 15, 2004;
10(22):
7529 - 7539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Casoli, M. C. Re, P. Monari, G. Furlini, G. Tosi, C. Gradozzi, P. P. Dall'Aglio, U. Bertazzoni, and R. S. Accolla
Human T-Cell Leukemia Virus Type II Directly Acts on CD34+ Hematopoietic Precursors by Increasing Their Survival Potential. Envelope-Associated HLA Class II Molecules Reverse This Effect
Blood,
April 1, 1998;
91(7):
2296 - 2304.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|